{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:50:58Z","timestamp":1791856258125,"version":"4.3.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is a complex chronic disease of which the underlying (molecular) mechanisms are mostly unknown. An estimated 0.89% of the global population is affected by ME\/CFS. Most patients experience a multitude of symptoms that severely affect their lives. These symptoms include post-exertional malaise, chronic fatigue, sleep disorder, impaired cognitive functions, flu-like symptoms, and chronic immune activation. Therapy focusses on symptom management, as there are no drugs available. Approximately 60% of patients develop ME\/CFS following an acute infection. Such a preceding infection may induce a state of trained immunity; defined as acquired, nonspecific, immunological memory of innate immune cells. Trained immune cells undergo long term epigenetic reprogramming, which leads to changes in chromatin accessibility, metabolism, and results in a hyperresponsive phenotype. Initially, trained immunity has only been demonstrated in peripheral blood monocytes and macrophages. However, more recent findings indicate that hematopoietic stem cells in the bone marrow are required for long-term persistence of trained immunity. While trained immunity is beneficial to combat infections, a disproportionate response may cause disease. We hypothesize that pronounced hyperresponsiveness of innate immune cells to stimuli could account for the aberrant activation of various immune pathways, thereby contributing to the pathophysiology of ME\/CFS. In this mini review, we elaborate on the concept of trained immunity as a factor involved in the pathogenesis of ME\/CFS by presenting evidence from other post-infectious diseases with symptoms that closely resemble those of ME\/CFS.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1483764","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T05:44:17Z","timestamp":1742881457000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Advocating the role of trained immunity in the pathogenesis of ME\/CFS: a mini review"],"prefix":"10.3389","volume":"16","author":[{"given":"Bart","family":"Humer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan A.","family":"Versnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"B1","article-title":"Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine","volume-title":"Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness","year":"2015"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","article-title":"Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME)","volume":"18","author":"Lim","year":"2020","journal-title":"J Transl Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1515\/reveh-2015-0026","article-title":"Review of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians","volume":"30","author":"Bested","year":"2015","journal-title":"Rev Environ Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2023.07.032","article-title":"Diagnosis and management of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"98","author":"Grach","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/17423953211043106","article-title":"Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"18","author":"Jason","year":"2022","journal-title":"Chronic Illn"},{"key":"B6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12967-019-1948-6","article-title":"The clinical value of cytokines in chronic fatigue syndrome","volume":"17","author":"Yang","year":"2019","journal-title":"J Transl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710519114","article-title":"Cytokine signature associated with disease severity in chronic fatigue syndrome patients","volume":"114","author":"Montoya","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12967-023-04179-3","article-title":"Proteomics and cytokine analyses distinguish myalgic encephalomyelitis\/chronic fatigue syndrome cases from controls","volume":"21","author":"Giloteaux","year":"2023","journal-title":"J Transl Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"21971","DOI":"10.1038\/s41598-023-48502-w","article-title":"Clinical characteristics of Long COVID patients presenting to a dedicated academic post-COVID-19 clinic in Central Texas","volume":"13","author":"Aziz","year":"2023","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1187163","article-title":"ME\/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature","volume":"10","author":"Komaroff","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147476","article-title":"Trained immunity: A \u201cnew\u201d weapon in the fight against infectious diseases","volume":"14","author":"Dagenais","year":"2023","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/imr.v323.1","article-title":"Trained immunity: General and emerging concepts","volume":"323","author":"Vuscan","year":"2024","journal-title":"Immunol Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0568-x","article-title":"Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection","volume":"21","author":"Aegerter","year":"2020","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity - basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.699563","article-title":"DAMPs and innate immune training","volume":"12","author":"Jentho","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1183066","article-title":"Trained immunity as a potential target for therapeutic immunomodulation in Duchenne muscular dystrophy","volume":"14","author":"Petrof","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840751","article-title":"Trained immunity in primary sjogren\u2019s syndrome: linking type I interferons to a pro-atherogenic phenotype","volume":"13","author":"Huijser","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","article-title":"The intersection of epigenetics and metabolism in trained immunity","volume":"54","author":"Fanucchi","year":"2021","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13223-018-0259-4","article-title":"Histone modifications and their role in epigenetics of atopy and allergic diseases","volume":"14","author":"Alaskhar Alhamwe","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108387","DOI":"10.1016\/j.celrep.2020.108387","article-title":"BCG vaccination induces long-term functional reprogramming of human neutrophils","volume":"33","author":"Moorlag","year":"2020","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13148-020-00960-z","article-title":"Changes in DNA methylation profiles of myalgic encephalomyelitis\/chronic fatigue syndrome patients reflect systemic dysfunctions","volume":"12","author":"Helliwell","year":"2020","journal-title":"Clin Epigenetics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201066","article-title":"Identification of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome-associated DNA methylation patterns","volume":"13","author":"Trivedi","year":"2018","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000512280","article-title":"The role of cell metabolism in innate immune memory","volume":"14","author":"Ferreira","year":"2022","journal-title":"J Innate Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.188","article-title":"Efficient generation of human natural killer cell lines by viral transformation","volume":"28","author":"Vogel","year":"2014","journal-title":"Leukemia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment","volume":"28","author":"Cirovic","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn4002","article-title":"Neonatal BCG vaccination is associated with a long-term DNA methylation signature in circulating monocytes","volume":"8","author":"Bannister","year":"2022","journal-title":"Sci Adv"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1294959","article-title":"COVID-19 and trained immunity: the inflammatory burden of long covid","volume":"14","author":"Gu","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00690-1","article-title":"Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19","volume":"23","author":"You","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1016\/j.cell.2023.07.019","article-title":"Epigenetic memory of coronavirus infection in innate immune cells and their progenitors","volume":"186","author":"Cheong","year":"2023","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101373","DOI":"10.1016\/j.xcrm.2023.101373","article-title":"Single-cell transcriptomics of the immune system in ME\/CFS at baseline and following symptom provocation","volume":"5","author":"Vu","year":"2024","journal-title":"Cell Rep Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"110258","DOI":"10.1016\/j.jpsychores.2020.110258","article-title":"Long-term impact of a Q-fever outbreak: An evaluation of health symptoms, health-related quality of life, participation and health care satisfaction after ten years","volume":"139","author":"Bronner","year":"2020","journal-title":"J Psychosom Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155884","article-title":"Fatigue following acute Q-fever: A systematic literature review","volume":"11","author":"Morroy","year":"2016","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"ofz296","DOI":"10.1093\/ofid\/ofz296","article-title":"Long-lasting transcriptional changes in circulating monocytes of acute Q fever patients","volume":"6","author":"Raijmakers","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome - Evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.5.471","article-title":"Seronegative\u2019 Sjogren\u2019s syndrome manifested as a subset of chronic fatigue syndrome","volume":"35","author":"Nishikai","year":"1996","journal-title":"Br J Rheumatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren\u2019s syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab688","article-title":"Serum interferon-alpha2 measured by single-molecule array associates with systemic disease manifestations in Sjogren\u2019s syndrome","volume":"61","author":"Huijser","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00299-2","article-title":"Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial","volume":"23","author":"Bramante","year":"2023","journal-title":"Lancet Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1483764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T05:44:32Z","timestamp":1742881472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1483764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2025.1483764"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1483764","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"article-number":"1483764"}}